Before a new medicinal product can be used in patients, it will pass a complex development process and marketing authorization procedure where pharmaceutical quality, therapeutic efficacy and safety of the product will be investigated.
actrevo’s clinical research unit develops medical solutions for innovative medicinal products. All new medicinal products undergo controlled clinical investigations, initially performed in a few healthy volunteers and a larger patient population later (phase I to IV trials).
For generic products, therapeutic efficacy is usually demonstrated in bioequivalence trials where the generic product is compared to a marketed product. actrevo serves both, sound scientific knowledge and extensive regulatory expertise to demonstrate the effectiveness of a new product.
Feel free to contact us at any time if you you are interested in our services.